Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
Learn the key differences between US and EU cosmetic regulations and how to export your products from the USA to Europe in full compliance.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
4 new substances were added to the SVHC list in June 2020, bringing the total to 209. 3 are toxic for reproduction and 1 is an endocrine disruptor. Companies must disclose SVHC presence in articles and comply with new ECHA requirements starting January 2021.
The European Commission's REACH Committee postponed the CTAC vote to consider a new European Parliament resolution. A qualified majority supports the draft decision, which restricts chromium trioxide use to specific functions. Industry groups advocate for a prompt vote.
Learn about the different types of Letters of Access required for biocides registration under the Biocides Regulation, including those for Section 95 Approved Suppliers and biocidal product Marketing Authorisations. Understand the differences between biocidal LoAs and REACH LoAs to ensure compliance with regulations.
The 13th ATP n�2018/1480 mandates a harmonised classification for methylisothiazolinone (MIT) since May 2020, impacting industries by requiring updates to Safety Data Sheets and labels. This classification affects skin sensitisation and environmental hazard categories.
Learn about the temporary guidance in the US for commercializing hand sanitizers during the pandemic. Understand the requirements and formulation needed to produce hand rubs. Discover the strict rules for placing hard surface disinfectants on the American market.
ECHA is implementing exceptional measures for REACH Authorisation dossiers due to Covid-19, allowing companies to update their applications for substances like OPE and NPE. This flexibility aims to support industries impacted by the pandemic while maintaining regulatory standards.